Therefore, TME BTLA + T-cells of DLBCL patients displayed a less differentiated phenotype, lower cytolytic function, and were more prone to proliferate in response to IL-2 than BTLA- T-cells [56]. This evidence concerns the gene BTLA and diffuse large B-cell lymphoma.